z-logo
open-access-imgOpen Access
F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B
Author(s) -
Guoqing Liu,
Jie Sun,
Zekun Li,
Zhenping Chen,
Wenman Wu,
Runhui Wu
Publication year - 2022
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2022017871
Subject(s) - serine protease , protease inhibitor (pharmacology) , mutation , factor ix , genetics , serine , biology , medicine , gene , protease , enzyme , biochemistry , virus , phosphorylation , antiretroviral therapy , viral load

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom